Skip to content
中文产业新闻评分50Chinese source

axatilimab 治疗 IPF 的 MAXPIRe II 期未达主要终点，Syndax 股价盘后大跌近 17%

临床II期失败！Syndax股价大跌17%

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.